Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
What is your brain tumor story? Click here to share it and join the community!
Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
**Sponsored Content**
An acoustic neuroma diagnosis comes with complex treatment decisions. Read why a multidisciplinary care team is crucial for your long-term recovery.
Join us July 19 to raise $50K for GBM research.
With the reigniting of the White House’s Cancer Moonshot Initiative, the ABTA recently joined the Brain Cancers Forum in Washington, D.C., to discuss opportunities in discovering treatments for brain cancers, including GBM.
Author, podcaster, and brain tumor survivor Bryan Bishop will take the stage as keynote of the 2023 ABTA National Conference. Discover how humor has carried Bryan through his 14-year battle.
**Sponsored Content**
After processing the initial shock of her GBM diagnosis at 36, Jeanneane M. created a “coping routine” that’s helped her get through difficult days and hold onto hope for her future.
Family and friends of Kelli McLaughlin are doing the hardest things: turning their grief into action to carry on Kelli’s legacy and vision of a future without brain tumors.
Join a free, half-day virtual meeting for patients and families dealing with brain metastases, led by Priya Kumthekar, MD, Director of the Brain Metastases Program at Northwestern University.
Register now for the nation’s largest patient-centric brain tumor conference, returning to Chicago and online this September.